MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmjresp-2025-003578

Медицинская библиотека · BMJ open respiratory research · 2026

Characterisation of chronic obstructive pulmonary disease (COPD) in never-smokers and ever-smokers from a population-based cohort.

Sönnerfors Pernilla, Jacobson Petra Kristina, Andersson Anders, Bjermer Leif Hilding, Blomberg Anders, Blomqvist Heléne, Erjefält Jonas S, Kolosenko Iryna, Malinovschi Andrei, Pincikova Terezia, Tufvesson Ellen, Wheelock Åsa M, Janson Christer, Persson Hans Lennart, Sköld Magnus

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Chronic obstructive pulmonary disease (COPD) in never-smokers may have other clinical characteristics than tobacco smoking-related COPD.

RESEARCH QUESTION: What are the risk factors, biomarkers, respiratory symptoms and health status in never-smoking individuals with COPD?

STUDY DESIGN AND

METHODS

We investigated never-smokers with COPD (n=154, mean age 60 years) from the population-based Swedish CArdioPulmonary bioImage Study (SCAPIS), and compared them with four control groups: never-smokers with normal lung function (n=281), current smokers with normal lung function (n=97), ex-smokers with COPD (n=103) and current smokers with COPD (n=55). COPD was defined as forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) less than the lower limit of normal (LNN) after bronchodilation. We examined fractional exhaled nitric oxide (FeNO), blood biomarkers, respiratory symptoms, health status, medical history and living conditions.

RESULTS

The never-smoker COPD group reported more respiratory symptoms and worse health status than never-smokers with normal lung function, but fewer symptoms, milder airflow limitation and better health status compared with ex-smokers and smokers with COPD. Never-smokers with COPD had more self-reported asthma. Moreover, never-smokers with COPD had higher Immunoglobulin E sensitisations to a mix of aeroallergens, higher geometrical mean FeNO levels and blood eosinophil counts than never-smokers with normal lung function. When participants with self-reported asthma were excluded, never-smokers with COPD still had more wheeze, cough and higher FeNO.

CONCLUSION

Never-smokers with COPD had more respiratory symptoms and elevated markers of type-2 inflammation, suggesting they might represent a distinct clinical phenotype which may differ from smoking-related COPD. They may therefore need to be treated and followed differently.

TRIAL REGISTRATION NUMBER: NCT03049202.

Для цитирования: Sönnerfors Pernilla, Jacobson Petra Kristina, Andersson Anders, Bjermer Leif Hilding, Blomberg Anders, Blomqvist Heléne, Erjefält Jonas S, Kolosenko Iryna, Malinovschi Andrei, Pincikova Terezia, Tufvesson Ellen, Wheelock Åsa M, Janson Christer, Persson Hans Lennart, Sköld Magnus. Characterisation of chronic obstructive pulmonary disease (COPD) in never-smokers and ever-smokers from a population-based cohort.. BMJ open respiratory research. 2026. DOI: 10.1136/bmjresp-2025-003578.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.